SCHEMBL7457739

SCHEMBL7457739

CCCN(CCC)C1Cc2cc3c(cc2C1)CN(S(=O)(=O)c1cccc(Cl)c1)C3

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ DRD3 P35462 1/20 0.44
▸ MMP2 P08253 1/20 0.42
▸ FYN P06241 1/20 0.42
▸ HTR1A P08908 4/20 0.42
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ KDM2B Q8NHM5 1/20 0.41
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ AKR1C3 P42330 1/20 0.40
▸ HSD11B1 P28845 1/20 0.39
▸ DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7450611 0.87 FYN (0.45) ALDH1A1MEN1KMT2ADRD3FYN
SCHEMBL7449830 0.84 MCOLN3 (0.44) DRD3FYNHTR1AAKR1C3
SCHEMBL8108257 0.81 DRD3 (0.48) ALDH1A1DRD3FYNHTR1AHTR2A
SCHEMBL8103882 0.76 FYN (0.42) ALDH1A1MEN1KMT2ADRD3FYN
SCHEMBL7455176 0.73 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AKDM2BMAPK1
SCHEMBL12228075 0.68 ALDH1A1 (0.66) ALDH1A1MEN1KMT2AMMP2
SCHEMBL7403093 0.68 DRD3 (0.59) ALDH1A1DRD3FYNCYP2D6CYP2C9
SCHEMBL7861355 0.68 DRD3 (0.55) ALDH1A1DRD3FYNHTR1ACYP2D6
SCHEMBL10726996 0.67 ALDH1A1 (0.86) ALDH1A1MEN1KMT2AMMP2MAPK1
SCHEMBL8688726 0.67 DRD3 (0.62) ALDH1A1MEN1KMT2ADRD3FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6084130-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN COMPANY (US) 2000-07-04 — — US disclosed
EP-0923542-A1 ARYL SUBSTITUTED CYCLIC AMINES AS SELECTIVE DOPAMINE D3 LIGANDS PHARMACIA & UPJOHN COMPANY (US) 1999-06-23 — — EP disclosed
WO-1997045403-A1 ARYL SUBSTITUTED CYCLIC AMINES AS SELECTIVE DOPAMINE D3 LIGANDS PHARMACIA & UPJOHN COMPANY (US) 1997-12-04 — — WO disclosed
Send feedback